Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Photochemistry and Photobiology|January 6, 2007
Simulation of ozone depletion using ambient irradiance supplemented with UV lampsS Díaz, C Camilión, J Escobar, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 29, 2014
Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND studyF Viazzi, D Garneri, G Leoncini, et al.
Biochemical and Biophysical Research Communications|April 16, 1998
Growth properties and growth factor responsiveness in skin fibroblasts from centenariansG Tesco, M Vergelli, E Grassilli, et al.
Neuroscience Letters|March 15, 1996
No evidence of linkage between schizophrenia and D2 dopamine receptor gene locus in Italian pedigreesE Grassi, M Mortilla, L Amaducci, et al.
Biochemical and Biophysical Research Communications|September 13, 1996
c-fos/c-jun expression and AP-1 activation in skin fibroblasts from centenariansE Grassilli, E Bellesia, P Salomoni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 10, 1997
Evaluation of the cost of home care for terminally ill cancer patientsM Maltoni, C Travaglini, M Santi, et al.
Breast Cancer Research and Treatment|December 12, 2018
Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trialO Nanni, D Amadori, A De Censi, et al.
Human Molecular Genetics|July 1, 1996
Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrantR Sherrington, S Froelich, S Sorbi, et al.
Neurology|November 1, 1993
Analysis of the c-FOS gene on chromosome 14 and the promoter of the amyloid precursor protein gene in familial Alzheimer's diseaseE I Rogaev, W J Lukiw, G Vaula, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 17, 2018
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡P Conte, A Frassoldati, G Bisagni, et al.
Pageof 20